Mark W. J. Strachan

8.7k total citations · 1 hit paper
146 papers, 5.8k citations indexed

About

Mark W. J. Strachan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Mark W. J. Strachan has authored 146 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Surgery and 28 papers in Epidemiology. Recurrent topics in Mark W. J. Strachan's work include Diabetes Management and Research (33 papers), Diabetes Treatment and Management (21 papers) and Diabetes and associated disorders (19 papers). Mark W. J. Strachan is often cited by papers focused on Diabetes Management and Research (33 papers), Diabetes Treatment and Management (21 papers) and Diabetes and associated disorders (19 papers). Mark W. J. Strachan collaborates with scholars based in United Kingdom, Germany and United States. Mark W. J. Strachan's co-authors include Brian M. Frier, Jackie F. Price, Ian J. Deary, Rebecca M. Reynolds, Fiona M.E Ewing, Riccardo E. Marioni, L. Jaap Kappelle, Geert Jan Biessels, Rachel A. Whitmer and Frank L.J. Visseren and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Mark W. J. Strachan

139 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions

2013 434 citations Mark W. J. Strachan et al. profile →

Peers

Countries citing papers authored by Mark W. J. Strachan

Since Specialization

Citations

This map shows the geographic impact of Mark W. J. Strachan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. J. Strachan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. J. Strachan more than expected).

Fields of papers citing papers by Mark W. J. Strachan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. J. Strachan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. J. Strachan. The network helps show where Mark W. J. Strachan may publish in the future.

Co-authorship network of co-authors of Mark W. J. Strachan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. J. Strachan. A scholar is included among the top collaborators of Mark W. J. Strachan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. J. Strachan. Mark W. J. Strachan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Commonly used C‐peptide assays show differing associations with CGM metrics 2025 ·Diabetes Obesity and Metabolism ·Catriona Clarke, Mark W. J. Strachan, Fraser W. Gibb	0
2	Changes in continuous glucose monitoring metrics and predictors of improvement 12 months after conversion from Freestyle Libre to Freestyle Libre 2 2023 ·Diabetic Medicine ·Roland H. Stimson, Anna R. Dover, Mark W. J. Strachan, Rohana J. Wright, Shareen Forbes, Fraser W. Gibb	8
3	P11.84.A PHASE 1 TRIAL OF MARIZOMIB ALONE AND IN COMBINATION WITH PANOBINOSTAT IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) 2023 ·Neuro-Oncology ·(unknown), (unknown), Mark W. J. Strachan, (unknown), (unknown), Jayne Vogelzang, Keith L. Ligon, Sanda Alexandrescu, Patricia Baxter, Nicholas A. Vitanza, (unknown), (unknown), Ying Yuan, Wendy B. London, Michelle Monje	1
4	Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a single centre case series 2023 ·The Journal of Laryngology & Otology ·(unknown), (unknown), Kirsten Stewart, (unknown), (unknown), Devraj Srinivasan, Lucy Wall, (unknown), Mark W. J. Strachan, Iain J. Nixon	10
5	Retinal venular tortuosity and fractal dimension predict incident retinopathy in adults with type 2 diabetes: the Edinburgh Type 2 Diabetes Study 2021 ·Diabetologia ·(unknown), Rachel Forster, (unknown), (unknown), (unknown), Stela McLachlan, Tom MacGillivray, Mark W. J. Strachan, Jackie F. Price	27
6	Addition of hyaluronic acid to the FIB‐4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study 2021 ·Obesity Science & Practice ·(unknown), Stela McLachlan, Jonathan Fallowfield, Peter Hayes, Indra Neil Guha, Joanne R Morling, Stephen Glancy, Rachel Williamson, Rebecca M. Reynolds, Brian M. Frier, Nicola N. Zammitt, Jackie F. Price, Mark W. J. Strachan	5
7	Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study 2021 ·Diabetologia ·(unknown), Stela McLachlan, Rachel Forster, Mark W. J. Strachan, Ian J. Deary, Jackie F. Price	21
8	A study of diabetic ketoacidosis in the pregnant population in the United Kingdom: Investigating the incidence, aetiology, management and outcomes 2021 ·Diabetic Medicine ·C. Diguisto, Mark W. J. Strachan, David Churchill, (unknown), Marian Knight	26
9	Non‐invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study 2020 ·Liver International ·(unknown), Stela McLachlan, Jonathan Fallowfield, Patrick K. A. Kearns, Peter Hayes, Indra Neil Guha, Joanne R Morling, Stephen Glancy, Rachel Williamson, Rebecca M. Reynolds, Brian M. Frier, Nicola N. Zammitt, Jackie F. Price, Mark W. J. Strachan	13
10	Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammation 2020 ·Diabetologia ·(unknown), (unknown), (unknown), Rachel Forster, Stela McLachlan, Mark W. J. Strachan, Jackie F. Price	18
11	Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes 2019 ·BMC Medicine ·Paul McKeigue, Athina Spiliopoulou, Stuart J. McGurnaghan, Marco Colombo, Luke A. K. Blackbourn, Timothy J. McDonald, (unknown), Stephen S. Rich, (unknown), John McKnight, Mark W. J. Strachan, Alan W. Patrick, John Chalmers, Robert S. Lindsay, John R. Petrie, Thekkepat C. Sandeep, Andrew Collier, Sandra MacRury, Helen M. Colhoun	51
12	Predicting outcomes and complications following radioiodine therapy in Graves’ thyrotoxicosis 2018 ·Clinical Endocrinology ·(unknown), Nicola N. Zammitt, Anna R. Dover, Mark W. J. Strachan, Jonathan R. Seckl, Fraser W. Gibb	37
13	Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes 2016 ·Kidney International ·Boris Betz, Sara Jenks, Andrew D. Cronshaw, Douglas J. Lamont, Carolynn Cairns, Jonathan Manning, Jane Goddard, David J. Webb, John J. Mullins, Jeremy Hughes, Stela McLachlan, Mark W. J. Strachan, Jackie F. Price, Bryan R. Conway	62
14	Association between hepatic steatosis and non-alcoholic fatty liver disease and clot lysis dynamics in Type 2 diabetes: the Edinburgh Type 2 Diabetes Study (ET2DS) 2013 ·Diabetic Medicine ·Rachel Williamson, R. A. Ajjan, Katharina Heß, Saad Alzahrani, Rebecca M. Reynolds, Jackie F. Price, Mark W. J. Strachan	1
15	Davidson's 100 clinical cases 2012 ·Elsevier eBooks ·(unknown), Mark W. J. Strachan, (unknown), John A. Hunter	1
16	Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors 2012 ·Kidney International ·Bryan R. Conway, (unknown), (unknown), Sara Jenks, James W. Dear, Stela McLachlan, Mark W. J. Strachan, Jackie F. Price	46
17	Association of retinal arteriolar dilatation with lower verbal memory: the Edinburgh Type 2 Diabetes Study 2011 ·Diabetologia ·Jie Ding, Mark W. J. Strachan, F. Gerry R. Fowkes, Tien Yin Wong, Tom MacGillivray, Niall Patton, Tom A. Gardiner, Ian J. Deary, Jackie F. Price	19
18	Relationships between directly measured subcutaneous and visceral adipose, standard anthropometric measures and hepatic steatosis: the Edinburgh Type 2 Diabetes Study 2010 ·Diabetic Medicine ·(unknown), (unknown), Calum Gray, I. Howard Marshall, Stephen Glancy, Shareen Forbes, (unknown), Rebecca M. Reynolds, Jackie F. Price, Mark W. J. Strachan	1
19	The epidemiology of thyroid cancer in Scotland, 1960 - 1999 2003 ·Jennifer Weir, David Brewster, Mark W. J. Strachan	1
20	The care of students with insulin‐treated diabetes mellitus living in university accommodation: scope for improvement? 2000 ·Diabetic Medicine ·Mark W. J. Strachan, A C MacCuish, B M Frier	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact